Sun Pharmaceutical Industries gets warning letter from USFDA for Dadra facility

20 Jun 2024 Evaluate

Sun Pharmaceutical Industries has received warning letter from US Food and Drug Administration (USFDA) for its Dadra facility. The Warning Letter summarizes violations with respect to Current Good Manufacturing Practice (cGMP) regulations. The contents of the Warning Letter shall be made public by the USFDA in due course. 

In April 2024, USFDA has issued Official Action Indicated (OAI) status to Dadra facility. USFDA had conducted an inspection at Company’s Dadra facility from December 4, 2023 to December 15, 2023.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1720.00 0.40 (0.02%)
31-Dec-2025 12:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.00
Dr. Reddys Lab 1267.50
Cipla 1500.80
Zydus Lifesciences 912.35
Lupin 2102.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×